American Innovation Proclamation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Talent, Immigration, and U.S. Economic Competitiveness
Talent, Immigration, and U.S. Economic Competitiveness GORDON H. HANSON & MATTHEW J. SLAUGHTER | MAY 2013 Table of Contents About The Authors 1 Executive Summary 2 SECTION 1 The Contribution of Talent to American Innovation and Overall Competitiveness 4 SECTION 2 Immigration’s Contribution to U S Talent: Strong Past and Growing Importance Today 13 SECTION 3 Supply and Demand of STEM Talent in America: Immigrants Continue to Help Meet Growing Demand 23 SECTION 4 Conclusions 36 References 37 About the Authors Gordon H. Hanson is the Pacific Economic Cooperation Chair in International Economic Relations at UC San Diego (UCSD), where he is director of the Center on Emerging and Pacific Economies and founding co-director of the Policy Design and Evaluation Lab. At UCSD, he has faculty positions in the School of International Relations and Pacific Studies and the Depart- ment of Economics. Professor Hanson is also a Research Associate at the National Bureau of Economic Research. Matthew J. Slaughter is Associate Dean for Faculty and Signal Companies’ Professor of Management at the Tuck School of Business at Dartmouth. He is also a Research Associate at the National Bureau of Economic Research, an adjunct Senior Fellow at the Council on Foreign Relations, and a member of the Congressional Budget Office’s Panel of Economic Advisers. From 2005 to 2007, he served as a Member of the President’s Council of Economic Advisers. This report was sponsored and published by Compete America Coalition. The views expressed in this report are those of the authors. © 2013 Gordon H. Hanson and Matthew J. -
List of Active Bayer Companies with at Least a Share of 50% Last Update: 17.8.2020 Country Company
List of active Bayer companies with at least a share of 50% last update: 17.8.2020 Country Company Algeria Bayer Algerie S.P.A. Argentina Bayer S.A. Argentina Biagro S.A. Argentina Monsanto Argentina SRL Australia Bayer Australia Limited Australia Bayer CropScience Holdings Pty Ltd Australia Bayer CropScience Pty Limited Australia Cotton Growers Services Pty. Limited Australia Imaxeon Pty. Ltd. Australia Monsanto Australia Pty Ltd Bangladesh Bayer CropScience Ltd. Belgium Bayer Agriculture BVBA Belgium Bayer CropScience NV Belgium Bayer NV Bermuda MonSure Limited Bolivia Bayer Boliviana Ltda Bolivia Monsanto Bolivia S.A. Bosnia & Herzeg. Bayer d.o.o. Sarajevo Brazil Alkagro do Brasil Ltda Brazil Bayer S.A. Brazil D&PL Brasil Ltda Brazil Monsanto do Brasil Ltda. Brazil Rede Agro Fidelidade e Intermediacao S.A. Brazil Schering do Brasil Química e Farmacêutica Ltda. Brazil Stoneville Brasil Ltda. Bulgaria Bayer Bulgaria EOOD Burkina Faso Monsanto Burkina Faso SARL Chile Bayer Finance & Portfolio Management S.A. Chile Bayer Finance Ltda. Chile Bayer S.A. Chile Monsanto Chile, S.A. Costa Rica Bayer Business Services Costa Rica, SRL Costa Rica Bayer Medical S.R.L. Costa Rica Bayer S.A. Curacao Pianosa B.V. Germany Adverio Pharma GmbH - 1 - List of active Bayer companies with at least a share of 50% last update: 17.8.2020 Country Company Germany AgrEvo Verwaltungsgesellschaft mbH Germany Alcafleu Management GmbH & Co. KG Germany BGI Deutschland GmbH Germany Bayer 04 Immobilien GmbH Germany Bayer 04 Leverkusen Fußball GmbH Germany Bayer 04 Leverkusen -
Bridge to Permanent Immigration Or Temporary Labor? the H-1B Visa Program Is a Source of Both Ron Hira, Howard University
Bridge to Permanent Immigration or Temporary Labor? The H-1B Visa Program Is A Source of Both Ron Hira, Howard University Introduction Many members of the popular press, pundits, business and university leaders, and policy makers conflate and often confuse guest worker visas, such as the H-1B, with permanent immigration.11 Carly Fiorina, an advisor to John McCain’s presidential campaign in 2008 and former CEO of Hewlett-Packard, responded to a question about H-1Bs during the campaign this way, “It is in our economic interest to have really smart people wanting to come here. And so what's wrong with the H-1B visa system today, among other things, is that we curtail that program so tightly that the limits that Congress allows for H-1B visa entrance are usually filled within one week. So we have to find a more practical system for allowing smart, hard-working people to come into this country and it should be our goal to get them to stay here forever” (Bomey 2008). Reading the quote, one might expect that expanding the H-1B program is the critical change to immigration policy that is needed in order to keep skilled workers here permanently. While permanent residence allows foreign nationals to live and work in the United States permanently, guest worker visas like an H-1B allow them to live and work in the United States only temporarily (not “forever”) and under circumstances that restrict their ability to stay in the country if they don’t keep their position. These circumstances sometimes put guest workers in a precarious position that invites their exploitation, creates insecurity for them, and undermines the integrity of the labor market. -
H-1B Visa Season Is Here the U.S
Business Week Top News March 31, 2009, 12:01AM EST H-1B Visa Season Is Here The U.S. government begins accepting applications on Apr. 1, and all 85,000 H-1B visas available are expected to be used By Moira Herbst On Apr. 1, the U.S. Citizenship & Immigration Service (USCIS) will begin accepting applications for H-1B visas for skilled workers. The number of applications will reveal U.S. employers' current appetite for overseas workers. Because of the recession, the overall volume of applications is expected to be down from the previous two years, in which the offices were instantly flooded with applications from tech companies, outsourcing firms, school districts, and a variety of other employers. Still, it's widely believed that the 85,000 visas available under the cap will be used before the fiscal year begins on Oct. 1. That's because there is some pent-up demand from 2008 applicants who didn't receive visas, and because employers say there are positions they can't fill with U.S. labor, even as unemployment rises. "It's fair to say that American companies are likely to file for fewer visas [in 2009]," Robert Hoffman, a vice-president at Oracle (ORCL) and spokesman for Compete America, a lobbying group advocating for more avenues for skilled immigration, said in a Mar. 31 conference call. "Still, all the [85,000] visas will be needed. If we're going to get out of the recession, we're going to have to innovate our way out…Continued use of the H-1B visa program is critically important." U.S. -
Steven Sanders, Et Al. V. Bayer (AG) Aktiengesellschaft, Et Al. 03-CV-1546-Second Consolidated Amended Complaint
Q,^.IGiNAL &&,iN 2i 4- L UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK -_DOF x Consolidated Civil Action IN RE BAYER AG SECURITIES No. 03 CV 1546 (WHP) LITIGATION Class Action x 71 :n = SECOND CONSOLIDATED AMENDED COMPLAINT Jury Trial Demand MILBERG WEISS BERSHAD & SCHULMAN LLP Melvyn I. Weiss (MW-1392) Michael C . Spencer (MS-8874) Lee A. Weiss (LW-1130) Jennifer Sclar (JS-7313) One Pennsylvania Plaza New York, NY 10119 (212) 594-5300 Attorneys for Lead Plaintiff January 14, 2005 i • ' Table of Contents Page SUMMARY OF CLAIMS ...............................................................................................................2 JURISDICTION AND VENUE ...................................................................................................... 8 A. General Jurisdiction and Venue ............................................................................... 8 B. Subject Matter Jurisdiction Over Claims of Foreign Purchasers on Foreign Exchanges ................................................................................................................ 8 PARTIES .......................................................................................................................................12 RELEVANT EVENTS ..................................................................................................................14 A. Background of the Statin Market ...........................................................................14 B. FDA Approval and Introduction of Baycol; Early Safety Warnings -
NFTC Signs Letter Expressing Disappointment with Revision To
October 4, 2015 The Honorable John Kerry Secretary of State U.S. Department of State 2201 C Street, NW Washington, D.C. 20520 The Honorable Jeh Johnson Secretary of Homeland Security U.S. Department of Homeland Security 3801 Nebraska Avenue, NW Washington, D.C. 20528 Ms. Cecilia Muñoz Assistant to the President and Director of the Domestic Policy Council The White House 1600 Pennsylvania Avenue, NW Washington, D.C. 20500 Re: The October 2015 Visa Bulletin and Immediate Eligibility for Submission of Adjustment of Status Applications Dear Secretary Kerry, Secretary Johnson, and Director Muñoz, We write to express our extraordinary concern and deepest objections to the Department of State’s revision to the October 2015 visa bulletin, published on September 25, 2015. As you are by now well aware, the Department of State’s eleventh hour revision to the October 2015 visa bulletin, and the Department of Homeland Security’s corresponding refusal to accept adjustment of status applications based on the originally published October visa bulletin, has generated tremendous chaos, uncertainty and disappointment. Literally tens of thousands of high skilled foreign professionals with already-approved immigrant petitions and their immediate family members placed their hope and trust in the promises of the original October visa bulletin, published on September 9, 2015, regarding their eligibility to file their applications from October 1, 2015 to October 31, 2015. Page 2 of 3 For the overwhelming majority of these applicants, this was the first real sign of progress in an employment-based green card journey marred by untenable backlogs, many extending well beyond a decade. -
Notes to the Consolidated Financial Statements of the Bayer Group
Five-Year Summary Bayer Annual Report 2018 Five-Year Summary 2014 2015 2016 2017 2018 Bayer Group (€ million) Sales 41,339 46,085 34,943 35,015 39,586 EBITDA1 8,315 9,573 8,801 8,563 10,266 1 EBITDA before special items 8,685 10,256 9,318 9,288 9,547 1 EBITDA margin before special items (in %) 21.0 22.3 26.7 26.5 24.1 EBIT1 5,395 6,241 5,738 5,903 3,914 1 EBIT before special items 5,833 7,060 6,826 7,130 6,480 Income before income taxes 4,414 5,236 4,773 4,577 2,318 Net income (from continuing and discontinued operations) 3,426 4,110 4,531 7,336 1,695 1 Earnings per share (from continuing and discontinued operations) (€) 4.14 4.97 5.44 8.29 1.80 1 Core earnings per share (from continuing operations) (€) 5.89 6.82 6.67 6.64 5.94 Net cash provided by operating activities (from continuing and discontinued operations) 5,810 6,890 9,089 8,134 7,917 Net financial debt 19,612 17,449 11,778 3,595 35,679 2 Capital expenditures (as per segment table) 2,484 2,554 2,627 2,418 2,564 Bayer AG Total dividend payment 1,861 2,067 2,233 2,402 2,611 Dividend per share (€) 2.25 2.50 2.70 2.80 2.80 Innovation Research and development expenses (€ million) 3,537 4,274 4,405 4,504 5,246 Ratio of R&D expenses to sales – Pharmaceuticals (%) 15.6 16.0 16.7 16.2 15.5 Ratio of R&D expenses to sales – Crop Science (%) 10.3 10.7 11.7 11.7 13.0 Employees in research and development3 13,900 14,753 14,213 14,041 17,275 Employees 3 Number of employees (Dec. -
Networking and Information Technology Workforce Study
TABLE OF CONTENTS 1. Introduction ................................................................................................................. 1 1.1 Study Description ................................................................................................. 2 1.2 Study Background ................................................................................................ 2 1.3 Study Topics ......................................................................................................... 3 1.4 Country Selection ................................................................................................. 4 1.5 Methodology ........................................................................................................ 5 1.6 Defining NIT ........................................................................................................ 5 1.7 Defining the NIT Workforce ................................................................................ 6 1.8 Literature Overview ............................................................................................. 7 1.9 Relationship to Science and Engineering Workforce .......................................... 8 2. NIT Workforce in the United States ........................................................................... 9 2.1 Expected Demand for NIT Professionals ........................................................... 10 2.1.1 Size of the NIT Workforce ......................................................................... 10 2.1.2 Expected -
Glaxosmithkline Aims to Divest Many OTC Brands
OTC11-02-11p1&28FIN.qxd 8/2/11 11:52 Page 1 11 February 2011 COMPANY NEWS 3 GlaxoSmithKline aims to Valeant expands in CEE 3 with PharmaSwiss deal J&J loses sales of US$1.1bn 4 Boots faces up to tough market 5 divest many OTC brands Key brands boost Novartis OTC sales 6 GSK consumer races ahead 7 laxoSmithKline intends to divest non- to divest the non-core brands as soon as pos- Taisho holds steady in weak market 8 Gcore OTC brands with combined an- sible – hopefully before the end of the year – Vicks shipments lift OTC at P&G 9 nual sales of £500 million (C593 million). depending on buyer interest. Perrigo plans spring Allegra launch 10 Chief executive officer Andrew Witty said The announcement came as GlaxoSmith- Consumer Care grows at Merck & Co 11 the move would enable the company’s Con- Kline reported a 7% rise – 5% at constant ex- Omega reports strong quarter 12 sumer Healthcare division to focus more effec- change rates – in 2010 sales at the Consumer Winter woes hit Boiron 13 tively on its “priority or global” brands as well Healthcare division to £5.01 billion. Sales in Pfizer wants Consumer 14 as its operations in emerging markets. Consumer Healthcare’s OTC Medicines busi- to prove worth A spokesperson for GlaxoSmithKline told ness grew by 5% – 3% at constant exchange OTC bulletin that the company was currently rates – to £2.46 billion. GENERAL NEWS 15 compiling the lists of priority and non-core OTC brands, and hoped to release more details Recent deals with Meda and Valeant Perrigo faces lawsuit over 15 in the second quarter of the year. -
May 21, 2020 the Honorable Donald J. Trump
May 21, 2020 The Honorable Donald J. Trump President of the United States of America The White House Washington, DC 20500 The Honorable Secretary Michael Pompeo Department of State 2201 C Street, NW Washington, DC 20520 The Honorable Secretary Eugene Scalia Department of Labor 200 Constitution Avenue, NW Washington, DC 20210 The Honorable Acting Secretary Chad Wolf Department of Homeland Security Washington, DC 20528 Dear Mr. President and Honorable Secretaries, The undersigned organizations, speaking for a variety of sectors and geographies across the American economy, and small, medium, and large employers, are writing about the importance of the high-skilled workforce to America’s economic recovery. In particular, the undersigned represent employers that rely on a highly skilled, college-educated, science and engineering workforce, including nonimmigrant professionals, to innovate, produce, research, develop, and lead. At this critical juncture in our nation’s history, the ability to continue to do so is in the national interest. We urge you to avoid outcomes, even for temporary periods, that restrict employment-authorization terms, conditions, or processing of L-1, H-1B, F-1, or H-4 nonimmigrants. Constraints on our human capital are likely to result in unintended consequences and may cause substantial economic uncertainty if we have to recalibrate our personnel based on country of birth. We join you in your continued commitment to protect the health and economic well-being of Americans, and hope our attached Appendix is helpful as you consider weighty judgments on how to navigate this important moment. Respectfully submitted, 324 employers and trade, industry, and higher education associations and groups across the American economy focused on the high-skilled workforce (signatory list follows Appendix) APPENDIX Importance to the nation of the STEM workforce and avoiding artificial constraints to this workforce IMPORTANCE OF THE COLLEGE-EDUCATED STEM WORKFORCE, INCLUDING NONIMMIGRANTS STEM Jobs. -
September 19, 2012 to the MEMBERS of the U.S. HOUSE
September 19, 2012 TO THE MEMBERS OF THE U.S. HOUSE OF REPRESENTATIVES: The undersigned organizations ask for bipartisan passage of in the 112th Congress of H.R. 6429, “STEM Jobs Act of 2012,” to establish a new green card program for outstanding STEM advanced degree graduates. Such a reform would allow the American economy to spur innovation and create thousands of high-paying manufacturing and research jobs here in America. America has been greatly enriched by the contributions of gifted engineers, researchers, and scientists from around the world who have chosen to come here to study and innovate. However, our immigration system has failed to adapt in ways that help ensure we maintain this advantage. Each year, graduate students who complete advanced degrees in science, technology, engineering and mathematics (STEM) from America’s top universities are offered jobs here by U.S. employers. Hiring advanced degree STEM professionals is a key to creating and retaining jobs in a variety of sectors in our innovation economy. These are highly educated professionals who will create jobs wherever they settle, whether in the U.S. or elsewhere. Together, the undersigned represent many American employers who hire these highly educated professionals, as well as American high-tech employees. H.R. 6429 would prioritize legal immigration status for those earning STEM degrees from American graduate schools. The employer obligation to confirm that qualified American workers are not available would continue, as under current law. Our organizations appreciate the strong and sustained bipartisan congressional work on this critically important issue. We are also grateful for the thoughtful consultation on STEM visa issues with stakeholders by House leaders. -
Annual Report 1998 Expertise with Responsibility
Annual Report 1998 Expertise with Responsibility Bayer is a diversified, international chemicals and health care group. We offer our customers a wide variety of products and services in areas ranging from pharmaceuticals and crop protection to plastics, specialty chemicals and imaging technologies. Bayer is research-based and aims for technological leadership in its core activities. Our goals are to steadily increase corporate value and generate a high value added for the benefit of our stockholders, our employees and the community in every country in which we operate. We believe that our technical and commercial expertise involves a responsibility to work for the common good and contribute to sustainable development. Bayer: Success through Expertise with Responsibility. Bayer Key Data Bayer Group 1998 1997 Change in % Sales DM million 54,884 55,005 – 0.2 Operating result DM million 6,151 6,018 + 2.2 Income before income taxes DM million 5,336 5,108 + 4.5 Net income DM million 3,157 2,941 + 7.3 Gross cash flow DM million 6,602 6,480 + 1.9 Stockholders’ equity DM million 24,991 23,923 + 4.5 Total assets DM million 57,216 54,170 + 5.6 Capital expenditures DM million 5,165 4,559 + 13.3 Employees at year end 145,100 144,600 + 0.3 Personnel expenses DM million 15,854 15,442 + 2.7 Research and development expenses DM million 3,920 3,878 + 1.1 Bayer AG 1998 1997 Change in % Total dividend payment DM million 1,461 1,388 + 5.3 Dividend per share DM 2.00 1.90 + 5.3 Tax credit DM 0.65 0.81 - 19.8 Published by Bayer AG, 51368 Leverkusen, This complete version of the Annual Report Germany is published in English and German.